Lifeway Foods Shareholder Edward Smolyansky Comments on Termination of Poison Pill
EDWARD SMOLYANSKY, KEY LWAY SHAREHOLDER: TERMINATION OF POISON PILL MARKS IMPORTANT INFLECTION POINT FOR LIFEWAY SHAREHOLDERS AS GOVERNANCE QUESTIONS MOUNT AHEAD OF THE ELECTION
Image: Benzinga
Edward Smolyansky, Lifeway Foods' largest shareholder, praised the termination of the company's poison pill strategy, which had limited shareholder rights for nearly nineteen months. He highlighted the need for improved governance and accountability as Lifeway approaches its upcoming annual meeting.
- 01The poison pill strategy was terminated after nearly nineteen months, following pressure from Institutional Shareholder Services (ISS).
- 02Smolyansky criticized the Board for its lack of transparency and accountability during the poison pill's enforcement.
- 03The removal of the poison pill allows for greater shareholder rights and strategic flexibility moving forward.
- 04Lifeway's governance issues are under scrutiny as shareholders prepare for the June 17 Annual Meeting, where they can express dissatisfaction with the Board.
- 05Smolyansky emphasizes the importance of transparency and long-term value for all shareholders in Lifeway's next phase.
Advertisement
In-Article Ad
Edward Smolyansky, the largest shareholder and former COO of Lifeway Foods, Inc. (NASDAQ: LWAY), commented on the company's recent decision to terminate its poison pill strategy, a defensive measure that restricted shareholder rights for nearly nineteen months. Smolyansky noted that the termination followed a rare recommendation from Institutional Shareholder Services (ISS) to vote against the entire Board, highlighting a troubling pattern of governance where changes only occur under external pressure. He pointed out that the Board failed to justify the poison pill's existence and has not adequately addressed accountability and transparency issues. With significant changes in Lifeway's ownership structure, including the exit of Danone as a major shareholder, Smolyansky believes the company should now focus on enhancing shareholder rights and maximizing long-term value. As Lifeway approaches its Annual Meeting on June 17, shareholders are encouraged to voice their dissatisfaction with the Board's actions, signaling a demand for improved governance practices.
Advertisement
In-Article Ad
The termination of the poison pill opens avenues for Lifeway shareholders to regain rights and influence over corporate governance, addressing long-standing concerns about accountability.
Advertisement
In-Article Ad
Reader Poll
Do you support the termination of the poison pill strategy at Lifeway Foods?
Connecting to poll...
Read the original article
Visit the source for the complete story.